European Society of Clinical Microbiology and Infectious Diseases

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1016/j.cmi.2018.01.002 Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
https://doi.org/10.1021/acsnano.6b06040 Diverse Applications of Nanomedicine
https://doi.org/10.1016/s1473-3099(20)30484-9 Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
https://doi.org/10.1016/j.cmi.2020.03.026 COVID-19, SARS and MERS: are they closely related?
https://doi.org/10.1016/j.nmni.2015.02.007 The global threat of antimicrobial resistance: science for intervention
https://doi.org/10.1016/j.progpolymsci.2018.06.001 PDMS with designer functionalities—Properties, modifications strategies, and applications
https://doi.org/10.1302/0301-620x.103b1.bjj-2020-1381.r1 The EBJIS definition of periprosthetic joint infection
https://doi.org/10.1016/j.idc.2019.03.001 Human Monkeypox
https://doi.org/10.2807/ese.18.04.20380-en Overview of molecular typing methods for outbreak detection and epidemiological surveillance
https://doi.org/10.1111/j.1469-0691.1996.tb00193.x Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems
https://doi.org/10.1016/j.cmi.2019.10.031 Burden of bacterial bloodstream infection—a brief update on epidemiology and significance of multidrug-resistant pathogens
https://doi.org/10.1038/s41564-024-01705-x Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study
https://doi.org/10.1111/j.1469-0691.2004.00942.x Antimicrobial resistance of Acinetobacter spp. in Europe
https://doi.org/10.1038/s41579-018-0098-9 Developmental roadmap for antimicrobial susceptibility testing systems
https://doi.org/10.1016/j.cmi.2017.11.001 Practical issues in implementing whole-genome-sequencing in routine diagnostic microbiology
https://doi.org/10.1016/j.lfs.2019.116797 Chrysin: Pharmacological and therapeutic properties
https://doi.org/10.1016/j.tifs.2018.08.001 Antibiotic resistance in foodborne bacteria
https://doi.org/10.1128/aac.00126-11 Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem on Mucoid and Nonmucoid Pseudomonas aeruginosa Biofilms
https://doi.org/10.1016/j.ijid.2020.01.042 MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
https://doi.org/10.1128/msphere.00334-18 Transcriptome Assembly and Profiling of Candida auris Reveals Novel Insights into Biofilm-Mediated Resistance
https://doi.org/10.1016/s2214-109x(23)00019-0 An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations
https://doi.org/10.1016/j.ijid.2020.02.043 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation
https://doi.org/10.1016/j.ijid.2018.11.008 Monkeypox — Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era
https://doi.org/10.1016/j.ijid.2021.11.040 Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts
https://doi.org/10.1128/iai.00283-22 Sex and Gender Differences in Bacterial Infections
https://doi.org/10.1016/j.cmi.2016.10.022 Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives
https://doi.org/10.1128/aac.06486-11 In Vivo Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem in Pseudomonas aeruginosa Biofilm Infection
https://doi.org/10.1016/j.cmi.2019.05.019 ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children
https://doi.org/10.1016/s0140-6736(20)30868-0 SARS-CoV-2 shedding and infectivity
https://doi.org/10.2807/1560-7917.es.2022.27.19.2100746 Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021
https://doi.org/10.1177/2050640620967898 A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group
https://doi.org/10.1155/2020/7656919 Biochemistry, Safety, Pharmacological Activities, and Clinical Applications of Turmeric: A Mechanistic Review
https://doi.org/10.1016/j.ijid.2022.08.002 Understanding the rebound of influenza in the post COVID-19 pandemic period holds important clues for epidemiology and control
https://doi.org/10.1007/s40121-022-00635-7 Legionnaires’ Disease: Update on Diagnosis and Treatment
https://doi.org/10.4161/auto.6880 HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells
https://doi.org/10.1016/j.cmi.2017.11.012 How to: identify non-tuberculous Mycobacterium species using MALDI-TOF mass spectrometry
https://doi.org/10.1172/jci97116 Inherited p40phox deficiency differs from classic chronic granulomatous disease
https://doi.org/10.1093/cid/cix227 The Not-So-Good Prognosis of Streptococcal Periprosthetic Joint Infection Managed by Implant Retention: The Results of a Large Multicenter Study
https://doi.org/10.1515/jcim-2019-0203 An overview on red algae bioactive compounds and their pharmaceutical applications
https://doi.org/10.1177/1934578x19850354 Bioactive Compounds and Health Benefits of Artemisia Species
https://doi.org/10.1016/j.ijid.2022.05.058 Increased outbreaks of monkeypox highlight gaps in actual disease burden in Sub-Saharan Africa and in animal reservoirs
https://doi.org/10.15698/mic2018.07.638 Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms
https://doi.org/10.3390/pathogens10091165 Human Babesiosis in Europe
https://doi.org/10.1016/j.cmi.2023.08.016 European society of Clinical Microbiology and Infectious Diseases guidelines on diagnosis and treatment of brain abscess in children and adults
https://doi.org/10.1097/qco.0000000000000554 Herpes simplex virus encephalitis update
https://doi.org/10.1016/j.cmi.2020.05.019 Review of trials currently testing treatment and prevention of COVID-19
https://doi.org/10.1007/s00405-015-3855-7 Salivary acinic cell carcinoma: reappraisal and update
https://doi.org/10.1016/j.ijid.2020.04.035 COVID-19–We urgently need to start developing an exit strategy
https://doi.org/10.1016/j.cmi.2017.07.013 Human resources estimates and funding for antibiotic stewardship teams are urgently needed
https://doi.org/10.1155/2022/9653244 Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting
https://doi.org/10.1016/j.cmi.2016.09.006 Consensus numbering system for the rifampicin resistance-associated rpoB gene mutations in pathogenic mycobacteria
https://doi.org/10.1016/j.bioflm.2019.100010 Minimum information guideline for spectrophotometric and fluorometric methods to assess biofilm formation in microplates
https://doi.org/10.1016/j.lfs.2019.117104 Xanthophyll: Health benefits and therapeutic insights
https://doi.org/10.1016/j.cmi.2017.03.018 Key considerations on nebulization of antimicrobial agents to mechanically ventilated patients
https://doi.org/10.1016/j.cmi.2017.12.008 How to: Surveillance of Clostridium difficile infections
https://doi.org/10.1302/0301-620x.103b1.bjj-2020-2417 Infographic: The EBJIS definition of periprosthetic joint infection
https://doi.org/10.1016/j.lanepe.2021.100181 The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey
https://doi.org/10.2807/1560-7917.es2014.19.7.20708 Intensified environmental surveillance supporting the response to wild poliovirus type 1 silent circulation in Israel, 2013
https://doi.org/10.1007/s00259-019-04393-6 Joint EANM/ESNR and ESCMID-endorsed consensus document for the diagnosis of spine infection (spondylodiscitis) in adults
https://doi.org/10.1128/aac.01393-12 High β-Lactamase Levels Change the Pharmacodynamics of β-Lactam Antibiotics in Pseudomonas aeruginosa Biofilms
https://doi.org/10.1016/j.cmi.2018.09.008 How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates
https://doi.org/10.1016/j.jcv.2013.11.013 Hepatitis E: An emerging infection in high income countries
https://doi.org/10.2807/1560-7917.es.2020.25.2.1900112 Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016
https://doi.org/10.2807/1560-7917.es2014.19.7.20709 Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013
https://doi.org/10.1016/j.ijid.2020.02.052 Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak
https://doi.org/10.3389/fsci.2024.1298248 Real-time genomic surveillance for enhanced control of infectious diseases and antimicrobial resistance
https://doi.org/10.1016/j.tmaid.2018.04.014 Infectious disease profiles of Syrian and Eritrean migrants presenting in Europe: A systematic review
https://doi.org/10.1016/j.ijid.2022.06.047 Vaccination for monkeypox prevention in persons with high-risk sexual behaviours to control on-going outbreak of monkeypox virus clade 3.
https://doi.org/10.1016/j.cmi.2018.01.003 Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?
https://doi.org/10.1016/j.cmi.2020.04.014 Toxoplasma gondii-specific IgG avidity testing in pregnant women
https://doi.org/10.1128/jcm.00873-23 A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI, ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC
https://doi.org/10.3389/fcimb.2020.00181 Current and Future Point-of-Care Tests for Emerging and New Respiratory Viruses and Future Perspectives
https://doi.org/10.1002/ana.26512 Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors
https://doi.org/10.1111/j.1600-0463.2004.apm1120604.x DNA extraction and PCR assays for detection of Toxoplasma gondii
https://doi.org/10.1016/j.cmi.2024.08.006 Invasive fungal disease in the immunocompromised host: changing epidemiology, new antifungal therapies, and management challenges
https://doi.org/10.1038/s41598-021-93115-w Interlaboratory study for the evaluation of three microtiter plate-based biofilm quantification methods
https://doi.org/10.3390/antibiotics10030299 Mortality Following Clostridioides difficile Infection in Europe: A Retrospective Multicenter Case-Control Study
https://doi.org/10.2807/1560-7917.es.2022.27.26.2100704 A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018
https://doi.org/10.3390/diagnostics10100764 A Lateral Flow Immunoassay for the Rapid Identification of CTX-M-Producing Enterobacterales from Culture Plates and Positive Blood Cultures
https://doi.org/10.1016/j.idnow.2021.11.007 Changing profile of encephalitis: Results of a 4-year study in France
https://doi.org/10.1186/s13756-020-00835-1 Education and training programmes for infection prevention and control professionals: mapping the current opportunities and local needs in European countries
https://doi.org/10.1016/j.cmi.2020.09.024 National case fatality rates of the COVID-19 pandemic
https://doi.org/10.3389/fmicb.2018.01498 Evaluating Streptococcus mutans Strain Dependent Characteristics in a Polymicrobial Biofilm Community
https://doi.org/10.1016/j.bioflm.2023.100147 Combining phages and antibiotic to enhance antibiofilm efficacy against an in vitro dual species wound biofilm
https://doi.org/10.1016/j.cmi.2024.03.029 The impact of armed conflict on the development and global spread of antibiotic resistance: a systematic review
https://doi.org/10.1136/bmjopen-2018-027683 Analysis of the challenges in implementing guidelines to prevent the spread of multidrug-resistant gram-negatives in Europe
https://doi.org/10.1016/j.cmi.2019.06.033 Unconventional diagnostic tests for Lyme borreliosis: a systematic review
https://doi.org/10.1093/cid/ciad481 Magistral Phage Preparations: Is This the Model for Everyone?
https://doi.org/10.1016/j.cmi.2022.12.019 Clostridioides difficile infection (CDI): A pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI)
https://doi.org/10.1093/jac/dkad194 In vivo emergence of a still uncommon resistance to fidaxomicin in the urgent antimicrobial resistance threat Clostridioides difficile
https://doi.org/10.1007/s10096-023-04638-1 A systematic review of the use of bacteriophages for in vitro biofilm control
https://doi.org/10.1186/s13054-023-04527-1 International survey of antibiotic dosing and monitoring in adult intensive care units
https://doi.org/10.1016/j.cmi.2022.12.010 Alveolar echinococcosis in immunocompromised hosts
https://doi.org/10.1038/s43586-024-00377-5 Phage therapy
https://doi.org/10.1016/j.steroids.2020.108661 Hepcidin, an overview of biochemical and clinical properties
https://doi.org/10.1097/qco.0000000000000820 Mycobacterial skin infection
https://doi.org/10.1016/j.ijid.2023.10.001 Global prevalence of respiratory virus infections in adults and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis
https://doi.org/10.1016/j.ijid.2019.10.017 Control of the 2018–2019 dengue fever outbreak in Oman: A country previously without local transmission
https://doi.org/10.1016/j.ttbdis.2021.101759 Are other tick-borne infections overlooked in patients investigated for Lyme neuroborreliosis? A large retrospective study from South-eastern Sweden
https://doi.org/10.1016/j.ijid.2022.09.013 Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view?